March 2, 2017 / 7:37 AM / 5 months ago

BRIEF-SOBI gets EMA approval for higher capacity production for Elocta

1 Min Read

March 2 (Reuters) - Swedish Orphan Biovitrum

* Says gets EMA (European Medicines Agency) approval to increase production capacity of pharmaceutical substance for Elocta

* Says received approval for the grouped type II 15 K Variation for Elocta (efmoroctocog alfa)

* Says the variation involves several changes, including the approval of Elocta drug substance manufacturing in 15 000 litre scale bioreactors. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below